Canary Speech

Membership Level: Elite Bronze

Canary Speech is the leading AI-powered voice biomarker company, using patented real-time vocal analysis to identify cognitive and behavioral changes earlier than clinical screenings or noticeable symptoms. Their technology works quietly in the background of natural conversations, seamlessly fitting into patient-clinician interactions. By analyzing subtle vocal patterns with AI machine learning, Canary Speech provides real-time insights into conditions like anxiety, depression, mild cognitive impairment, and alzheimer’s. Canary Speech is led by seasoned life science executives Henry O’Connell and Jeff Adams.

More